Add BrightSurf on Google Email

Science News for June 13, 2026


Adding genetic data to steroid prescribing can help predict side effects

Researchers found that certain genetic variants increase the risk of steroid side effects, particularly osteoporosis and stroke. Integrating polygenic risk scores into steroid prescribing can improve risk assessment and identify patients at high risk, allowing for closer monitoring or alternative treatments.

SourceEuropean Society of Human Genetics·DateJun 13, 2026

Phthalate exposure in early life may lead to anxiety in adult male rats

A study presented at the Endocrine Society's annual meeting found that exposure to the plasticizer DEHP in early development can lead to increased anxiety-like behavior in adult male rats. The research suggests that humans exposed to endocrine disruptors before and shortly after birth may experience long-lasting behavioral changes.

SourceThe Endocrine Society·DateJun 13, 2026
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

EDCs found in breast milk and infant urine up to age 6 months

A study of 336 mother-infant pairs found that breast milk and infant urine contained over 50 different chemicals, including BPA and phthalates, which can interfere with hormones during baby's development. These chemicals were detected in breast milk and urine up to 6 months after birth.

SourceThe Endocrine Society·DateJun 13, 2026

Type 1 diabetes diagnoses surge among Puerto Rican teens

The study found a significant increase in type 1 diabetes cases among Hispanic/Latino adolescents in Puerto Rico, from 10.1 per 100,000 in 2009 to 24.1 in 2021, with an average annual increase of 4.1%. This trend has important implications for patient care and public health.

SourceThe Endocrine Society·DateJun 13, 2026
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Sugar-free diets may disrupt gut microbiome

Researchers found that eliminating sugar from a low-fat diet can lead to impaired glucose control, insulin resistance, and gut microbial imbalance. Balanced dietary carbohydrates are essential for supporting gut and immune homeostasis.

SourceThe Endocrine Society·DateJun 13, 2026

GLP-1s tied to elevated risk of fainting, dizziness

A recent study of 42,000 adults taking blood pressure medications and GLP-1s found higher rates of hypotension events, including dizziness and fainting. The study highlights a potential safety concern for patients aged 65 and older and those with diabetes.

SourceNorthwestern University·DateJun 13, 2026
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

Exercise decreases among people taking GLP-1 medication

A study found that adults taking GLP-1 receptor agonist medications experienced significant decreases in daily step counts and moderate-to-vigorous physical activity, highlighting the need for targeted interventions to promote exercise alongside obesity treatment.

SourceThe Endocrine Society·DateJun 13, 2026

Not all children with early puberty need the same level of testing or treatment

Children who start puberty earlier than usual may not need the same level of testing or treatment, according to a new Endocrine Society Clinical Practice Guideline. The guideline suggests different approaches for various subgroups, including monitoring girls with slow progression and using simpler testing methods.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJun 13, 2026

New test reads DNA much more comprehensively in rare genetic disorders

A new DNA test offers a much more complete picture of DNA than current standard diagnostics, leading to a diagnosis more often. The test can replace fifteen other tests, making it faster and more efficient for rare genetic disorders.

SourceRadboud University Medical Center·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJun 13, 2026

World first: First phase 3 trial of in vivo CRISPR therapy successfully completed CRISPR treatment comes one step closer to reality

A large-scale Phase 3 trial of CRISPR therapy has shown an 87% reduction in attacks for patients with hereditary angioedema. The treatment also improved quality-of-life scores and reduced the need for on-demand medication, paving the way for future genetic therapies.

SourceAmsterdam University Medical Center·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJun 13, 2026
GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

Forget single bad links, researchers take on whole phishing campaigns

Researchers create PhishLumos AI system to detect phishing campaigns by analyzing infrastructure clues, achieving 8-day faster detection than experts. The system uncovered over 190,000 new links, with 92% later flagged as malicious, outperforming content-centric approaches.

SourceTokyo Metropolitan University·JournalIEEE Access·DateJun 13, 2026